Publication: Pulmonary Mucormycosis secondary to Severe Acute Respiratory Illness due to Covid 19 Infection: A Case Report Authors
Files
Date
2022
Journal Title
Journal ISSN
Volume Title
Publisher
Nepalese Respiratory Society
Abstract
Abstract:
Patients diagnosed and hospitalized with SARS COV-2 are managed with corticosteroids due to its known benefits for the prevention of airway inflammation secondary to acute respiratory distress syndrome seen commonly in viral pneumonia. However, these patients carry a high risk of developing secondary bacterial and fungal infection. We present a case of 60-year-old male with COVID-19 pneumonia. The patient was diagnosed with pulmonary mucormycosis 18 days following admission. The patient was treated with broad-spectrum antibiotics, remdesivir and corticosteroids along with antifungals including voriconazole and amphotericin B with no significant improvement. However, even after extensive medical management patient was eventually intubated and succumbed to its complications. Mucormycosis although an uncommon infection should be considered due to extensive use of glucocorticoid therapy and concurrent comorbidities present among COVID-19 patients.
Description
Ashish Karthak
Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal
Ashish Shrestha
Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal
Naresh Gurung
Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal
Yuvaraj Bhusal
Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal
Rakesh Lama
Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal
Sulav Rayamajhi
Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal
Sanjeet Bhattarai
Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal
Asim Regmi
Department of Critical care Medicine, Nepal Mediciti Hospital, Nepal
Anup Ghimire
Department of Critical care Medicine, Nepal Mediciti Hospital, Nepal
Kishor Khanal
Department of Critical care Medicine, Nepal Mediciti Hospital, Nepal
Sanjeet K Shrestha
Department of Pulmonary, Critical care and Sleep Medicine, Nepal Mediciti Hospital, Nepal
Keywords
Pulmonary mucormycosis, Severe acute respiratory illness, Mortality